Stockreport

RHHBY to Advance Parkinson's Disease Drug to Late-Stage Development [Yahoo! Finance]

Prothena Corporation plc - Ordinary Shares  (PRTA) 
Last prothena corporation plc - ordinary shares earnings: 2/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.prothena.com
PDF Roche has a licensing agreement with Prothena PRTA for prasinezumab. The decision to advance prasinezumab to late-stage development was based on data from the phase I [Read more]